Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy

Fernandes, C.D.; Houdt, P.J. van; Heijmink, S.W.T.P.J.; Walraven, I.; Keesman, R.; Smolic, M.; ... ; Heide, U.A. van der (2018)

Article / Letter to editor

Background Post-radiotherapy locally recurrent prostate cancer (PCa) patients are candidates for focal salvage treatment. Multiparametric MRI (mp-MRI) is attractive for tumor localization. However, radiotherapy-induced tissue changes complicate image interpretation. To develop focal salvage strategies, accurate tumor localization and distinction from benign tissue is necessary. Purpose To quantitatively characterize radio-recurrent tumor and benign radiation-induced changes using mp-MRI, and investigate which sequences optimize the distinction between tumor and benign surroundings. Study Type Prospective case?control. Subjects Thirty-three patients with biochemical failure after external-beam radiotherapy (cases), 35 patients without post-radiotherapy recurrent disease (controls), and 13 patients with primary PCa (untreated). Field Strength/Sequences 3T; quantitative mp-MRI: T2-mapping, ADC, and Ktrans and kep maps. Assessment Quantitative image-analysis of prostatic regions, within and between cases, controls, and untreated patients. Statistical Tests Within-groups: nonparametric Friedman analysis of variance with post-hoc Wilcoxon signed-rank tests; between-groups: Mann?Whitney tests. All with Bonferroni corrections. Generalized linear mixed modeling to ascertain the contribution of each map and location to tumor likelihood. Results Benign imaging values were comparable between cases and controls (P?=?0.15 for ADC in the central gland up to 0.91 for kep in the peripheral zone), both with similarly high peri-urethral Ktrans and kep values (min?1) (median [range]: Ktrans?=?0.22 [0.14?0.43] and 0.22 [0.14?0.36], P?=?0.60, kep?=?0.43 [0.24?0.57] and 0.48 [0.32?0.67], P?=?0.05). After radiotherapy, benign central gland values were significantly decreased for all maps (P ≤ 0.001) as well as T2, Ktrans, and kep of benign peripheral zone (all with P ≤ 0.002). All imaging maps distinguished recurrent tumor from benign peripheral zone, but only ADC, Ktrans, and kep were able to distinguish it from benign central gland. Recurrent tumor and peri-urethral Ktrans values were not significantly different (P?=?0.81), but kep values were (P < 0.001). Combining all quantitative maps and voxel location resulted in an optimal distinction between tumor and benign voxels. Data Conclusion Mp-MRI can distinguish recurrent tumor from benign tissue. Level of Evidence: 2 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2018.

• All authors: Fernandes, C.D.; Houdt, P.J. van; Heijmink, S.W.T.P.J.; Walraven, I.; Keesman, R.; Smolic, M.; Ghobadi, G.; Poel, H.G. van der; Schoots, I.G.; Pos, F.J.; Heide, U.A. van der
• Date: 2018-12-25
• Journal: Journal of Magnetic Resonance Imaging
• Volume: 50
• Issue: 1
• Pages: 269 - 278
• DOI: doi:10.1002/jmri.26581